|
시장보고서
상품코드
2151482
단일 세포 단백질체학 시장 규모, 점유율, 동향 분석 보고서 : 제품 및 서비스별, 기술별, 워크플로우별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)Single-cell Proteomics Market Size, Share & Trends Analysis Report By Product & Services, By Technology, By Workflow, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
단일 세포 단백질체학 시장 요약
세계의 단일 세포 단백질체학 시장 규모는 2025년에 7억 710만 달러로 평가되며, 2026년 8억 770만 달러에서 2033년까지 20억 1,780만 달러로 확대될 것으로 예상되며, 2026년부터 2033년까지 연평균 성장률(CAGR)은 14.0%에 달할 것으로 예측됩니다.
북미가 시장을 주도하고 있으며, 2025년에는 매출 점유율의 46.4%를 차지했습니다. 시장의 성장은 정밀 의학, 신약 개발, 질병 연구 분야에서 단일세포 분석의 채택 확대는 물론, 질량 분석법, 다중 단백질체학 기술 및 고처리량 단일세포 분석 플랫폼의 발전에 힘입어 견인되고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 시장 : 변수, 동향, 범위
- 시장 계보 전망
- 시장 역학
- 업계 분석 도구
제4장 제품 및 서비스별 비즈니스 분석
- 단일 세포 단백질체학 시장 : 제품 및 서비스별 동향 분석
- 기기
- 소모품·시약
- 소프트웨어
- 서비스
제5장 기술별 비즈니스 분석
- 단일 세포 단백질체학 시장 : 기술별 동향 분석
- 질량 분석법에 기반한 단백질체학
- 질량 세포계측법에 기반한 단백질체학
- 항체를 이용한 단백질체학
- 이미징을 이용한 단백질체학
- 시퀀싱에 기반한 단백질체학
- 기타 기술
제6장 워크플로우별 비즈니스 분석
- 단일 세포 단백질체학 시장 : 워크플로우별 동향 분석
- 세포 분리와 조제
- 단백질 표지 및 바코드화
- 단백질 검출과 정량
- 데이터별 인수
- 데이터 분석과 해석
제7장 용도별 비즈니스 분석
- 단일 세포 단백질체학 시장 : 용도별 동향 분석
- 임상 진단
- Drug Discovery
- 기타
제8장 최종 용도별 비즈니스 분석
- 단일 세포 단백질체학 시장 : 최종 용도별 동향 분석
- 제약·바이오테크놀러지 기업
- 학술연구기관
- 병원 및 임상 연구 센터
- 수탁연구기관
- 기타 최종사용자
제9장 지역별 비즈니스 분석
- 단일 세포 단백질체학 시장 점유율 : 지역별, 2025년 & 2033년
- 북미
- 북미의 단일 세포 단백질체학 시장, 2021-2033년
- 미국
- 캐나다
- 멕시코
- 유럽
- 유럽의 단일 세포 단백질체학 시장, 2021-2033년
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
- 아시아태평양
- 아시아태평양의 단일 세포 단백질체학 시장, 2021-2033년
- 일본
- 중국
- 인도
- 호주
- 태국
- 한국
- 라틴아메리카
- 라틴아메리카의 단일 세포 단백질체학 시장, 2021-2033년
- 브라질
- 아르헨티나
- 중동 및 아프리카
- MEA의 단일 세포 단백질체학 시장, 2021-2033년
- 남아프리카공화국
- 사우디아라비아
- UAE
- 쿠웨이트
제10장 경쟁 구도
- 기업 분류
- 기업 점유율·포지셔닝 분석, 2025년
- 전략 매핑
- 기업 개요·리스트
- Thermo Fisher Scientific Inc.
- Bruker
- Danaher Corporation(SCIEX)
- Standard BioTools
- BD
- Agilent Technologies, Inc.
- Waters Corporation
- 10x Genomics
- Seer, Inc.
- Evosep Biosystems
- Cellenion
- Cytek Biosciences
- Quantum-Si Incorporated
Single-cell Proteomics Market Summary
The global single-cell proteomics market size was valued at USD 707.1 million in 2025 and is projected to grow from USD 807.7 million in 2026 to USD 2,017.8 million by 2033, at a CAGR of 14.0% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 46.4% in 2025. Market growth is driven by increasing adoption of single-cell analysis in precision medicine, drug discovery, and disease research, along with advancements in mass spectrometry, multiplexed proteomic technologies, and high-throughput single-cell analysis platforms.
Global Single-cell Proteomics Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global single-cell proteomics market report on the basis of product & services, technology, workflow, application, end use, and region.
- Product & Services Outlook (Revenue, USD Million, 2021 - 2033)
- Instruments
- Consumables & Reagents
- Software
- Services
- Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Mass Spectrometry-based Proteomics
- Mass Cytometry-based Proteomics
- Antibody-based Proteomics
- Imaging-based Proteomics
- Sequencing-based Proteomics
- Other Technologies
- Workflow Outlook (Revenue, USD Million, 2021 - 2033)
- Cell Isolation & Preparation
- Protein Labeling & Barcoding
- Protein Detection & Quantification
- Data Acquisition
- Data Analysis & Interpretation
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Clinical Diagnostics
- Drug Discovery
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Hospitals & Clinical Research Centers
- Contract Research Organizations
- Other End Users
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Product & Services Segment
- 1.1.1.2. Technology Segment
- 1.1.1.3. Workflow Segment
- 1.1.1.4. Application Segment
- 1.1.1.5. End Use Segment
- 1.1.1. Segment Definitions
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information or Data Analysis:
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.9.2. List of Secondary Sources
- 1.9.3. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing Adoption of Precision Medicine
- 3.2.1.2. Rising Demand for High-Resolution Cellular Analysis
- 3.2.1.3. Increasing Investments in Single-Cell Research
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Complexity of Single-cell Proteomics Data Analysis
- 3.2.2.2. High Cost of Advanced Proteomics Instruments
- 3.2.3. Market Opportunities Analysis
- 3.2.4. Market Challenges Analysis
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Economic landscape
- 3.3.2.5. Legal landscape
- 3.3.1. Porter's Five Forces Analysis
Chapter 4. Product & Services Business Analysis
- 4.1. Segment Dashboard
- 4.2. Single-cell Proteomics Market: Product & Services Movement Analysis
- 4.3. Instruments
- 4.3.1. Instruments Market, 2021-2033 (USD Million)
- 4.4. Consumables & Reagents
- 4.4.1. Consumables & Reagents Market, 2021-2033 (USD Million)
- 4.5. Software
- 4.5.1. Software Market, 2021-2033 (USD Million)
- 4.6. Services
- 4.6.1. Services Market, 2021-2033 (USD Million)
Chapter 5. Technology Business Analysis
- 5.1. Segment Dashboard
- 5.2. Single-cell Proteomics Market: Technology Movement Analysis
- 5.3. Mass Spectrometry-based Proteomics
- 5.3.1. Mass Spectrometry-based Proteomics Market, 2021-2033 (USD Million)
- 5.4. Mass Cytometry-based Proteomics
- 5.4.1. Mass Cytometry-based Proteomics Market, 2021-2033 (USD Million)
- 5.5. Antibody-based Proteomics
- 5.5.1. Antibody-based Proteomics Market, 2021-2033 (USD Million)
- 5.6. Imaging-based Proteomics
- 5.6.1. Imaging-based Proteomics Market, 2021-2033 (USD Million)
- 5.7. Sequencing-based Proteomics
- 5.7.1. Sequencing-based Proteomics Market, 2021-2033 (USD Million)
- 5.8. Other Technologies
- 5.8.1. Other Technologies Market, 2021-2033 (USD Million)
Chapter 6. Workflow Business Analysis
- 6.1. Segment Dashboard
- 6.2. Single-cell Proteomics Market: Workflow Movement Analysis
- 6.3. Cell Isolation & Preparation
- 6.3.1. Cell Isolation & Preparation Market, 2021-2033 (USD Million)
- 6.4. Protein Labeling & Barcoding
- 6.4.1. Protein Labeling & Barcoding Market, 2021-2033 (USD Million)
- 6.5. Protein Detection & Quantification
- 6.5.1. Protein Detection & Quantification Market, 2021-2033 (USD Million)
- 6.6. Data Acquisition
- 6.6.1. Data Acquisition Market, 2021-2033 (USD Million)
- 6.7. Data Analysis & Interpretation
- 6.7.1. Data Analysis & Interpretation Market, 2021-2033 (USD Million)
Chapter 7. Application Business Analysis
- 7.1. Segment Dashboard
- 7.2. Single-cell Proteomics Market: Application Movement Analysis
- 7.3. Clinical Diagnostics
- 7.3.1. Clinical Diagnostics Market, 2021-2033 (USD Million)
- 7.4. Drug Discovery
- 7.4.1. Drug Discovery Market, 2021-2033 (USD Million)
- 7.5. Others
- 7.5.1. Others Market, 2021-2033 (USD Million)
Chapter 8. End Use Business Analysis
- 8.1. Segment Dashboard
- 8.2. Single-cell Proteomics Market: End Use Movement Analysis
- 8.3. Pharmaceutical & Biotechnology Companies
- 8.3.1. Pharmaceutical & Biotechnology Companies Market, 2021-2033 (USD Million)
- 8.4. Academic & Research Institutes
- 8.4.1. Academic & Research Institutes Market, 2021-2033 (USD Million)
- 8.5. Hospitals & Clinical Research Centers
- 8.5.1. Hospitals & Clinical Research Centers Market, 2021-2033 (USD Million)
- 8.6. Contract Research Organizations
- 8.6.1. Contract Research Organizations Market, 2021-2033 (USD Million)
- 8.7. Other End Users
- 8.7.1. Other End Users Market, 2021-2033 (USD Million)
Chapter 9. Regional Business Analysis
- 9.1. Single-cell Proteomics Market Share By Region, 2025 & 2033
- 9.2. North America
- 9.2.1. North America Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.2.2. U.S.
- 9.2.2.1. Key Country Dynamics
- 9.2.2.2. Competitive Scenario
- 9.2.2.3. Regulatory Framework
- 9.2.2.4. U.S. Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.2.3. Canada
- 9.2.3.1. Key Country Dynamics
- 9.2.3.2. Competitive Scenario
- 9.2.3.3. Regulatory Framework
- 9.2.3.4. Canada Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.2.4. Mexico
- 9.2.4.1. Key Country Dynamics
- 9.2.4.2. Competitive Scenario
- 9.2.4.3. Regulatory Framework
- 9.2.4.4. Mexico Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3. Europe
- 9.3.1. Europe Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3.2. UK
- 9.3.2.1. Key Country Dynamics
- 9.3.2.2. Competitive Scenario
- 9.3.2.3. Regulatory Framework
- 9.3.2.4. UK Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3.3. Germany
- 9.3.3.1. Key Country Dynamics
- 9.3.3.2. Competitive Scenario
- 9.3.3.3. Regulatory Framework
- 9.3.3.4. Germany Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3.4. France
- 9.3.4.1. Key Country Dynamics
- 9.3.4.2. Competitive Scenario
- 9.3.4.3. Regulatory Framework
- 9.3.4.4. France Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3.5. Italy
- 9.3.5.1. Key Country Dynamics
- 9.3.5.2. Competitive Scenario
- 9.3.5.3. Regulatory Framework
- 9.3.5.4. Italy Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3.6. Spain
- 9.3.6.1. Key Country Dynamics
- 9.3.6.2. Competitive Scenario
- 9.3.6.3. Regulatory Framework
- 9.3.6.4. Spain Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3.7. Denmark
- 9.3.7.1. Key Country Dynamics
- 9.3.7.2. Competitive Scenario
- 9.3.7.3. Regulatory Framework
- 9.3.7.4. Denmark Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3.8. Sweden
- 9.3.8.1. Key Country Dynamics
- 9.3.8.2. Competitive Scenario
- 9.3.8.3. Regulatory Framework
- 9.3.8.4. Sweden Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.3.9. Norway
- 9.3.9.1. Key Country Dynamics
- 9.3.9.2. Competitive Scenario
- 9.3.9.3. Regulatory Framework
- 9.3.9.4. Norway Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.4. Asia Pacific
- 9.4.1. Asia Pacific Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.4.2. Japan
- 9.4.2.1. Key Country Dynamics
- 9.4.2.2. Competitive Scenario
- 9.4.2.3. Regulatory Framework
- 9.4.2.4. Japan Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.4.3. China
- 9.4.3.1. Key Country Dynamics
- 9.4.3.2. Competitive Scenario
- 9.4.3.3. Regulatory Framework
- 9.4.3.4. China Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.4.4. India
- 9.4.4.1. Key Country Dynamics
- 9.4.4.2. Competitive Scenario
- 9.4.4.3. Regulatory Framework
- 9.4.4.4. India Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.4.5. Australia
- 9.4.5.1. Key Country Dynamics
- 9.4.5.2. Competitive Scenario
- 9.4.5.3. Regulatory Framework
- 9.4.5.4. Australia Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.4.6. Thailand
- 9.4.6.1. Key Country Dynamics
- 9.4.6.2. Competitive Scenario
- 9.4.6.3. Regulatory Framework
- 9.4.6.4. Thailand Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.4.7. South Korea
- 9.4.7.1. Key Country Dynamics
- 9.4.7.2. Competitive Scenario
- 9.4.7.3. Regulatory Framework
- 9.4.7.4. South Korea Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.5. Latin America
- 9.5.1. Latin America Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.5.2. Brazil
- 9.5.2.1. Key Country Dynamics
- 9.5.2.2. Competitive Scenario
- 9.5.2.3. Regulatory Framework
- 9.5.2.4. Brazil Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.5.3. Argentina
- 9.5.3.1. Key Country Dynamics
- 9.5.3.2. Competitive Scenario
- 9.5.3.3. Regulatory Framework
- 9.5.3.4. Argentina Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.6. MEA
- 9.6.1. MEA Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.6.2. South Africa
- 9.6.2.1. Key Country Dynamics
- 9.6.2.2. Competitive Scenario
- 9.6.2.3. Regulatory Framework
- 9.6.2.4. South Africa Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.6.3. Saudi Arabia
- 9.6.3.1. Key Country Dynamics
- 9.6.3.2. Competitive Scenario
- 9.6.3.3. Regulatory Framework
- 9.6.3.4. Saudi Arabia Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.6.4. UAE
- 9.6.4.1. Key Country Dynamics
- 9.6.4.2. Competitive Scenario
- 9.6.4.3. Regulatory Framework
- 9.6.4.4. UAE Single-cell Proteomics Market, 2021-2033 (USD Million)
- 9.6.5. Kuwait
- 9.6.5.1. Key Country Dynamics
- 9.6.5.2. Competitive Scenario
- 9.6.5.3. Regulatory Framework
- 9.6.5.4. Kuwait Single-cell Proteomics Market, 2021-2033 (USD Million)
Chapter 10. Competitive Landscape
- 10.1. Company Categorization
- 10.2. Company Market Share/ Position Analysis, 2025
- 10.3. Strategy Mapping
- 10.4. Company Profiles/Listing
- 10.4.1. Thermo Fisher Scientific Inc.
- 10.4.1.1. Overview
- 10.4.1.2. Financial Performance
- 10.4.1.3. Product Benchmarking
- 10.4.1.4. Strategic Initiatives
- 10.4.2. Bruker
- 10.4.2.1. Overview
- 10.4.2.2. Financial Performance
- 10.4.2.3. Product Benchmarking
- 10.4.2.4. Strategic Initiatives
- 10.4.3. Danaher Corporation (SCIEX)
- 10.4.3.1. Overview
- 10.4.3.2. Financial Performance
- 10.4.3.3. Product Benchmarking
- 10.4.3.4. Strategic Initiatives
- 10.4.4. Standard BioTools
- 10.4.4.1. Overview
- 10.4.4.2. Financial Performance
- 10.4.4.3. Product Benchmarking
- 10.4.4.4. Strategic Initiatives
- 10.4.5. BD
- 10.4.5.1. Overview
- 10.4.5.2. Financial Performance
- 10.4.5.3. Product Benchmarking
- 10.4.5.4. Strategic Initiatives
- 10.4.6. Agilent Technologies, Inc.
- 10.4.6.1. Overview
- 10.4.6.2. Financial Performance
- 10.4.6.3. Product Benchmarking
- 10.4.6.4. Strategic Initiatives
- 10.4.7. Waters Corporation
- 10.4.7.1. Overview
- 10.4.7.2. Financial Performance
- 10.4.7.3. Product Benchmarking
- 10.4.7.4. Strategic Initiatives
- 10.4.8. 10x Genomics
- 10.4.8.1. Overview
- 10.4.8.2. Financial Performance
- 10.4.8.3. Product Benchmarking
- 10.4.8.4. Strategic Initiatives
- 10.4.9. Seer, Inc.
- 10.4.9.1. Overview
- 10.4.9.2. Financial Performance
- 10.4.9.3. Product Benchmarking
- 10.4.9.4. Strategic Initiatives
- 10.4.10. Evosep Biosystems
- 10.4.10.1. Overview
- 10.4.10.2. Financial Performance
- 10.4.10.3. Product Benchmarking
- 10.4.10.4. Strategic Initiatives
- 10.4.11. Cellenion
- 10.4.11.1. Overview
- 10.4.11.2. Financial Performance
- 10.4.11.3. Product Benchmarking
- 10.4.11.4. Strategic Initiatives
- 10.4.12. Cytek Biosciences
- 10.4.12.1. Overview
- 10.4.12.2. Financial Performance
- 10.4.12.3. Product Benchmarking
- 10.4.12.4. Strategic Initiatives
- 10.4.13. Quantum-Si Incorporated
- 10.4.13.1. Overview
- 10.4.13.2. Financial Performance
- 10.4.13.3. Product Benchmarking
- 10.4.13.4. Strategic Initiatives
- 10.4.1. Thermo Fisher Scientific Inc.
